Is circulating D-dimer level a better prognostic indicator than CEA in resectable colorectal cancer? Our experience on 199 cases

International Journal of Biological Markers

Volumn 25, Issue 3, 2010, Pages 171-176

  Pedrazzani, Corrado ^a   Cerullo, Guido ^a   Marrelli, Daniele ^a   Fernandes, Eduardo ^b   Carlucci, Filippo ^a   Corso, Giovanni ^a   Bettarini, Francesca ^a   De Stefano, Alfonso ^a   Roviello, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Carcinoembryonic antigen; Colorectal carcinoma; D dimer; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; D DIMER; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE CLASSIFICATION; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; SURGICAL TECHNIQUE;

EID: 78650809920     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500308     Document Type: Article

References (28)

1. Ozturk M, Sengul N, Dagli M, Kosar A, Bavbek N. Global fibrinolytic capacity in colorectal cancer: a new clue to occult fibrinolysis. Clin Appl Thromb Hemost 2003; 9: 151-4. (Pubitemid 36665983)
2. Kockar C, Kockar O, Ozturk M, Dagli M, Bavbek N, Kosar A. Global fibrinolytic capacity increased exponentially in metastatic colorectal cancer. Clin Appl Thromb Hemost 2005; 11: 227-30. (Pubitemid 40548008)
3. Kilic M, Yoldas O, Keskek M, et al. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis 2008; 10: 238-41. (Pubitemid 351284674)
4. Buccheri G, Torchio P, Ferrigno D. Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer 2003; 97: 3044-52. (Pubitemid 36676259)
5. Kohli M, Fink LM, Spencer HJ, Zent CS. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul Fibrinolysis 2002; 13: 1-5. (Pubitemid 34461695)
6. Mirshahi SS, Pujade-Lauraine E, Soria C, et al. D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy. Prognostic significance for the success of anticancer treatment. Cancer 1992; 69: 2289-92.
7. Dirix LY, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer 2002; 86: 389-95.
8. Uharcek P, Mlyncek M, Ravinger J. Elevation of serum CA 125 and D-dimer levels associated with rupture of ovarian endometrioma. Int J Biol Markers 2007; 22: 203-5. (Pubitemid 350081630)
9. Oya M, Akiyama Y, Yanagida T, Akao S, Ishikawa H. Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg Today 1998; 28: 373-8.
10. Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol 2001; 31: 388-94.
11. Xu G, Zhang YL, Huang W. Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients. World J Gastroenterol 2004; 10: 922-3.
12. Edwards CM, Warren J, Armstrong L, Donnelly PK. D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg 1993; 80: 1404-5. (Pubitemid 23345099)
13. Blackwell K, Hurwitz H, Lieberman G, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer 2004; 101: 77-82.
14. Bick RL, Baker WF. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC). Thromb Res 1992; 65: 785-90.
15. Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haematol 1989; 71: 65-70.
16. Francis CW, Connaghan DG, Scott WL, Marder VJ. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction. Circulation 1987; 75: 1170-7.
17. Ahmed S, Siddiqui AK, Iqbal U, et al. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report. Eur J Haematol 2004; 72: 213-6.
18. Kobayashi T, Gabazza EC, Taguchi O, et al. Type I collagen metabolites as tumor markers in patients with lung carcinoma. Cancer 1999; 85: 1951-7.
19. Roselli M, Mineo TC, Basili S, et al. Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers. Thromb Haemost 2003; 89: 177-84.
20. Gadducci A, Baicchi U, Marrai R, et al. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD) and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type and lymph node status. Gynecol Oncol 1993; 49: 354-8.
21. Montemurro P, Conese M, Altomare DF, Memeo V, Colucci M, Semeraro N. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma. Int J Clin Lab Res 1995; 25: 195-200. (Pubitemid 3013381)
22. Dupuy E, Habib A, Lebret M, Yang R, Levy-Toledano S, Tobelem G. Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alfa. J Thromb Haemost 2003; 1: 1096-102.
23. Wojtukiewicz MZ, Sierko E, Klement P, Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia 2001; 3: 371-84.
24. Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans 2002; 30: 173-7.
25. Chiarugi V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumour matrix. Mol Biotechnol 2002; 21: 85-90.
26. Bugge TH, Kombrinck KW, Xiao Q, et al. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood 1997; 90: 4522-31.
27. Tominaru Y, Yano M, Takachi K, et al. Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer. J Am Coll Surg 2006; 202: 139-45.
28. Aliustaoglu M, Yumuk PF, Gumus M, et al. D-dimer. Can it be a marker for malignant gastric lesions? Acta Oncol 2004; 43: 770-1.